Cauldron is an Industrial Biomanufacturing company founded in 2021 and based in Orange, Australia. It has raised $20M in total funding, most recently a Series A in 2024.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Jan 1, 2024 | Series A | $9.5M | — | — |
No articles ingested yet for Cauldron. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
Cauldron's continuous precision-fermentation system, pairing a novel bioreactor design with a proprietary growth-medium formulation so fermentation can run uninterrupted for months rather than in batches. The company has demonstrated a 10,000-litre system running continuously for more than eight months without contamination or genetic drift, which it cites as proof of industrially relevant scale. By increasing volumetric productivity and asset utilization, the platform targets a 30-50% reduction in cost of goods versus conventional batch fermentation, helping precision-fermentation companies produce proteins, fats, and other ingredients economically. Cauldron offers the technology to scale partners' bioprocesses.
1 patent on file, but none with both an extractable figure and an abstract on Google Patents yet.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗